• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.29% Nasdaq Down0.03%

    More On 083790.KQ

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    CrystalGenomics, Inc. (083790.KQ)

    -KOSDAQ
    12,700.00 Down 250.00(1.93%) May 22, 2:00AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    CrystalGenomics, Inc.
    Tower A, Korea Bio Park
    5th Floor
    Seongnam, 463-400
    South Korea - Map
    Phone: 82 3 1628 2700
    Fax: 82 3 1628 2701
    Website: http://www.cgxinc.com

    Details 
    Index Membership:N/A
    Sector:N/A
    Industry:N/A
    Full Time Employees:N/A

    Business Summary 

    CrystalGenomics, Inc., a biopharmaceutical company, operates as a structural chemoproteiomics-based drug discovery and development company in South Korea. Its lead development candidate is NSAID (CG100649), which is a tissue specific anti-inflammatory agent with cardiovascular, gastrointestinal, and renal safety profiles. The company’s drug candidates also include CG200745, a histone deacetylase inhibitor for cancer, which is in Phase I clinical trial; and CG400549, an antibiotic candidate for methicillin resistant staphylococcus aureus and vancomycin resistant staphylococcus aureus that has completed Phase I studies in Europe, as well as is in Phase IIa study in the United States. CrystalGenomics, Inc. is based in Seongnam, South Korea.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on CrystalGenomics, Inc.

    Key Executives 
     PayExercised
    Dr. Ho-Jin Chang , 53
    Head of Discovery Biology
    N/AN/A
    Willim Schmdit ,
    Exec. Officer
    N/AN/A
    Hui-Sung Lee ,
    Exec. Officer
    N/AN/A
    Jong-Ryu Choi , 56
    Exec. Officer and Member of Committee of Research Department
    N/AN/A
    Doh-Young Lee ,
    Exec. Officer
    N/AN/A
    Amounts are as of Dec 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in KRW.